DLGAP1-AS2
gene geneOn this page
Also known as MGC11082
Summary
DLGAP1-AS2 (DLGAP1 antisense RNA 2, HGNC:28146) is a long non-coding RNA gene on chromosome 18p11.31.
Biomarker of hepatocellular carcinoma.
Source: NCBI Gene 84777 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28146 |
| Approved symbol | DLGAP1-AS2 |
| Name | DLGAP1 antisense RNA 2 |
| Location | 18p11.31 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | MGC11082 |
| Ensembl gene | ENSG00000262001 |
| Ensembl biotype | lncRNA |
| Entrez | 84777 |
| RNAcentral | URS000075EE3F — lncRNA, 923 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000572856, ENST00000573177, ENST00000687483, ENST00000689896, ENST00000691824, ENST00000692104, ENST00000693339, ENST00000715378, ENST00000715379, ENST00000715380, ENST00000715381
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000572856 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002642757 | 3606554 | 3608336 |
| ENSE00002654065 | 3603738 | 3604215 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 85.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.1459 / max 360.7937, expressed in 1287 samples.
FANTOM5 promoters (14 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 169209 | 4.1912 | 819 |
| 169207 | 1.4729 | 482 |
| 169212 | 1.1436 | 177 |
| 169214 | 0.5966 | 192 |
| 169210 | 0.5639 | 186 |
| 169216 | 0.4767 | 209 |
| 169208 | 0.4112 | 120 |
| 169211 | 0.3486 | 173 |
| 169217 | 0.3249 | 56 |
| 169213 | 0.2790 | 117 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.07 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 79.67 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 79.62 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.33 | gold quality |
| left adrenal gland | UBERON:0001234 | 77.83 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.70 | gold quality |
| adenohypophysis | UBERON:0002196 | 77.36 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.16 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.98 | gold quality |
| adrenal cortex | UBERON:0001235 | 75.76 | gold quality |
| adrenal gland | UBERON:0002369 | 75.67 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.66 | gold quality |
| sural nerve | UBERON:0015488 | 75.46 | gold quality |
| left ovary | UBERON:0002119 | 75.38 | gold quality |
| right uterine tube | UBERON:0001302 | 75.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.77 | gold quality |
| endocervix | UBERON:0000458 | 74.75 | gold quality |
| pituitary gland | UBERON:0000007 | 74.49 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.47 | gold quality |
| tibial nerve | UBERON:0001323 | 74.41 | gold quality |
| rectum | UBERON:0001052 | 74.25 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 73.65 | gold quality |
| granulocyte | CL:0000094 | 73.43 | gold quality |
| body of uterus | UBERON:0009853 | 73.40 | gold quality |
| spleen | UBERON:0002106 | 73.26 | gold quality |
| right ovary | UBERON:0002118 | 73.14 | gold quality |
| ventricular zone | UBERON:0003053 | 72.30 | gold quality |
| left uterine tube | UBERON:0001303 | 72.25 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.20 | gold quality |
| bone marrow cell | CL:0002092 | 71.69 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.02 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation. (PMID:33195697)
- The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10. (PMID:33301605)
- LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer. (PMID:34454450)
- LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target. (PMID:34981339)
- METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m[6]A/c-Myc-dependent aerobic glycolysis. (PMID:35972892)
- Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers. (PMID:36121088)
- DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc. (PMID:36222892)
- Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. (PMID:36376892)
- The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis. (PMID:37817462)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.